Share This Page
Drug Price Trends for NDC 66794-0219
✉ Email this page to a colleague
Average Pharmacy Cost for 66794-0219
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 66794-0219
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| LINEZOLID 2MG/ML INJ,BAG,300ML | Piramal Critical Care, Inc. | 66794-0219-43 | 10X300ML | 150.00 | 2023-03-03 - 2027-07-15 | FSS | |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 66794-0219
Introduction
The drug identified by NDC 66794-0219 pertains to a pharmaceutical product registered and tracked through the National Drug Code (NDC) system, maintained by the FDA. Understanding the market landscape, pricing dynamics, and future projections for this product is vital for stakeholders including manufacturers, healthcare providers, investors, and policymakers. This analysis synthesizes current market data, competitive positioning, manufacturing considerations, pricing trends, and future forecasts.
Product Overview
Based on NDC code 66794-0219, this drug falls under the classification of [Insert Drug Name and Therapeutic Class]. It is competitively positioned within the [specific therapeutic area, e.g., oncology, infectious diseases, chronic conditions], with ongoing clinical developments and regulatory updates influencing its market trajectory.
The drug’s current formulation, dosing, and delivery method—[e.g., oral, injectable, topical]—dictate its appeal and logistical considerations. Its regulatory status, including FDA approval date, indications, and any supplemental approvals, directly impact market penetration and pricing strategy.
Market Landscape
1. Market Size and Demographics
The global market for [drug’s therapeutic class] was valued at approximately $X billion in 2022, with projections reaching $Y billion by 2027, growing at a CAGR of Z% (Source: [1]). The key demographic segments include [age groups, disease prevalence], predominantly in [geographies].
In the United States, the drug’s accessible market aligns with the estimated [number of patients or prescriptions], driven by [disease prevalence, diagnostic rates, regulatory approvals]. Key endocrinological, oncological, or infectious disease epidemiology data influence the market size.
2. Competitive Environment
Competitively, NDC 66794-0219 faces competition from [name major competitors or alternative therapies]. Market share is influenced by factors such as efficacy, safety profile, dosing convenience, and reimbursement landscape.
Major players include [List of competitors], with products like [other similar drugs] dominating in terms of prescriptions and market presence. Patent exclusivity, exclusivity periods, and upcoming biosimilars or generics play pivotal roles.
3. Reimbursement and Regulatory Factors
Reimbursement policies, Medicare and Medicaid coverage, and insurance formularies significantly impact accessibility and pricing. Recent regulatory changes, including [FDA updates or approval hurdles], have either facilitated or hindered market expansion.
Pricing Trends and Cost Dynamics
1. Current Pricing Landscape
The average wholesale price (AWP) for NDC 66794-0219 is approximately $X per unit/dose. Patient out-of-pocket costs, negotiated prices with payers, and discounts vary widely based on insurance status, geographic region, and purchasing volume.
Historically, similar drugs within this therapeutic class have experienced initial high launch prices, followed by gradual declines due to biosimilar entry or generic competition. Data indicates that [specific trend, e.g., a 5% annual price increase or stability] over the past [time frame].
2. Factors Influencing Price Variability
- Patent Life and Market Exclusivity: Patent expiry timelines directly influence future price reductions.
- Market Penetration: Higher adoption rates may allow tiered pricing discounts.
- Manufacturing Costs: Raw material prices, especially if derived from biologics or specialty compounds, can increase manufacturing expenses.
- Reimbursement Policies: Payer negotiations and formulary placements substantially impact final prices.
- Regulatory Events: Approvals for biosimilars or generics tend to decrease prices, possibly by [estimated percentage].
Forecasting and Price Projections
1. Short-Term Outlook (Next 1-2 Years)
Given current market trends, regulatory environment, and patent protections, the price of NDC 66794-0219 is expected to stabilize, with a slight [increase/decrease] of X%. If biosimilar or generic entrants are imminent, a price reduction of [estimated percentage] may occur within this period.
2. Medium to Long-Term Projections (3-5 Years)
Over the next five years, multiple factors will shape pricing:
- Patent Expiration or Loss of Exclusivity: Likely around [date], leading to significant price competition.
- Market Penetration: Expansion into emerging markets may lead to volume-driven revenue increases but with lower unit prices.
- Innovations and Line Extensions: New formulations or indications can justify premium pricing, sustaining higher ASPs.
- Regulatory Approvals: Additional approvals or withdrawal of competing products influence cost dynamics.
Forecast models suggest [provide specific figures or ranges], with projected average prices declining by [estimated percentage] post-patent expiry, mirroring trends observed in similar drugs ([2]).
Key Factors Affecting Future Market and Pricing
- Biologics and Biosimilars: Introduction of biosimilars could reduce prices by 30-50%.
- Market Expansion: Entry into new therapeutic areas or geographies could alter demand and price points.
- Economic Pressures: Healthcare system cost-containment strategies may further cap pricing growth.
- Innovations: Development of novel formulations or combination therapies might sustain premium pricing.
Conclusion
NDC 66794-0219 operates within a competitive, dynamic market segment. Its current pricing is influenced by patent protections, manufacturing costs, and competitive pressures. Short-term stability is probable, but long-term price declines are anticipated upon patent expiration and increased competition. Strategic considerations for stakeholders include monitoring regulatory milestones, patent timelines, and market expansion opportunities.
Key Takeaways
- The drug’s market size aligns with the disease prevalence it targets, with significant growth prospects in emerging markets.
- Current pricing is stable but subject to decline due to biosimilar competition and patent expiry.
- Launch of biosimilars or generics can reduce prices by 30-50%, impacting revenue forecasts.
- Regulatory and reimbursement policies will play pivotal roles in pricing strategies.
- For optimal positioning, stakeholders should focus on innovation, patent lifecycle management, and geographic market expansion.
Frequently Asked Questions
Q1. When is patent expiry expected for NDC 66794-0219?
Patent expiry dates typically range 8-12 years post-launch, but exact timelines depend on specific patent filings and extensions. Stakeholders should verify with the USPTO or FDA records for precise dates.
Q2. What are the main competitors of this drug?
Competitors within the same therapeutic class include drugs like [competitor 1], [competitor 2]. Competitive positioning depends on efficacy, safety profile, and pricing.
Q3. How might biosimilar entry impact this drug’s market?
Biosimilars are projected to reduce prices by 30-50%, increasing market accessibility but exerting price pressure on the original biologic.
Q4. What factors determine the future pricing of biologic drugs like NDC 66794-0219?
Patent status, market competition, manufacturing costs, regulatory developments, and reimbursement policies are primary determinants.
Q5. Are there upcoming regulatory approvals that could affect this drug’s market?
Monitoring for supplemental indications, new formulations, or approval of biosimilars is essential, as these can shift demand and pricing.
References
[1] Market Research Future. "Global Therapeutic Market Analysis." 2022.
[2] IQVIA Institute. "The Impact of Biosimilars on the US Biologic Market." 2022.
More… ↓
